why choose us

Clinical Trials Search

Showing 13,070 of 132,366 result(s)
Evaluating the Episodic Future Thinking Intervention for Reducing Cigarette Consumption in Cigarette Smokers

Status: COMPLETED

Condition: Cigarette Smoking-Related Carcinoma

Interventions: BEHAVIORAL: Smoking Cessation Intervention - Receive active EFT stimulus
BEHAVIORAL: Smoking Cessation Intervention (control) - Receive control E

Date: 2023-04-11

Cannabis Observations on Brain Waves, Retrieval, and Attention: Experiment 1

Status: COMPLETED

Condition: Cannabis

Interventions: Self-Directed Use (ad-libitum)

Date: 2023-04-11

Vancomycin and Tobramycin Powder Use in Acute Open Fractures

Status: COMPLETED

Condition: Infections

Interventions: Antibiotics: Cephalosporin, 2-grams, intravenous (IV), or clindamycin (900mg) ; vancomycin (20mg;kg), intravenous (IV).

Date: 2023-04-11

Retrospective Registry Study of Patients With Cancer Treated With High-dose Methotrexate

Status: Completed

Condition: Acute Kidney Injury

Interventions: High-dose methotrexate

Date: 2023-04-11

Clinical Study of Recombinant Mycobacterium Tuberculosis Fusion Protein for 65-year-olds and Above

Status: NOT_YET_RECRUITING

Condition: Latent Tuberculosis Infection

Interventions:

Dosage form:injection.
Main ingredients and contents: Recombinant Mycobacterium tuberculosis fusion protein, 0.3ml, 0.5ml, 1.0ml per bottle.

Date: 2023-04-11

Study to Evaluate EBA, Safety and Tolerability of Carbapenems in Adults With Pulmonary Tuberculosis

Status: COMPLETED

Condition: Pulmonary Tuberculosis

Interventions: Meropenem 6g intravenously over 6 hours once daily on days 1-14.

Date: 2023-04-11

A Study of PMG1015 Injection in Idiopathic Pulmonary Fibrosis Subjects

Status: Completed

Condition: IPF

Interventions: Strength: 100 mg;2 mL;vial.
Dosage and Administration: Intravenous infusion of PMG1015 at 15 mg;kg, 30 mg;kg and 40 mg;k

Date: 2023-04-11

Colloidal Oatmeal, Diaper Rash, Preterm Neonates

Status: ACTIVE_NOT_RECRUITING

Condition: Diaper Rash

Interventions: The colloid oatmeal had the following component: Colloidal Oat (5gm), stearic acid 5, cretoctryl alcohol 2.5, cetyl alcohol 2.5, koh 02, potassium sor

Date: 2023-04-11

Does Weightbearing Crutch Technology Impact Patient Compliance?

Status: Completed

Condition: Fracture Healing

Interventions: Feedback on how much weight patients are exerting on their crutch;injured lower extremity (measured via Smart Crutch Tip) will be delivered to th

Date: 2023-04-11

Effect of Intraocular Lens (IOL) Centration and Tilt on Visual Performance With Clareon® Vivity® IOL Implantation

Status: NOT_YET_RECRUITING

Condition: Cataract

Interventions: No intervention

Date: 2023-04-11